Prostate Cancer - Global Market Outlook (2017-2026)

Published Date : Sep 2019 | No. of Pages : 155 Pages | Category : Healthcare

According to Stratistics MRC, the Global Prostate Cancer market is growing at a CAGR of 10.3% during the forecast period. Some of the key factors such as improved diagnosis and frequency rates in industrial economies, rapidly growing geriatric population, and the high demand for effective treatments are propelling the market growth. However, high price for treatment, lack of awareness and short accessibility of health care services in the small regions which are hampering the growth of the market.

Prostate cancer is one of the most ordinary types of cancer in men which is caused by the irregular growth of tissues in the prostate gland that produce seminal fluid. Various types of prostate cancer grow up slowly and may require minimal or no treatment, other types are hostile and can increase quickly. This needs novel drugs that will address the unmet desires low cost and enhanced survival time.

Based on Therapy, Biologic therapy is a treatment for patients with prostate cancer that involves utilize of existing organisms, substances plagiaristic from living organisms, or laboratory formed versions of living organisms. Biological therapies use diverse ways to rouse the immune system and stop tumor cells from rising. For patients with cancer, biological therapies may be used to treat the cancer itself or the side effects of other cancer treatments.

By Geography, Asia Pacific is expected to exhibit the utmost growth on account of the existence of untapped opportunity in the rising economies such as India and China. As well, rising healthcare expenditure has caused an increase in the implementation of technically advanced commodities, which is likely to boost county market growth.

Some of the key players profiled in the Prostate Cancer Market include Astellas, Inc., AstraZeneca plc, Bristol Myers Squibb (BMS), Johnson & Johnson, NOVARTIS, Sanofi S.A, TOLMAR Inc., Tokai Pharmaceuticals, Progenics Pharmaceuticals Inc., OncoGenex Pharmaceuticals Inc., OncBioMune Pharmaceuticals Inc., Endo Pharmaceuticals, and Bayer Pharma AG.

Types Covered:
• Hormone Sensitive
• Hormone Refractory

Therapies Covered:
• Focal Therapies
• Biologic Therapy
• Cryosurgery
• Immunotherapy
• Therapeutic Vaccines
• Radiation Therapy
• Chemotherapy
• Surgery
• Targeted Therapy
• Bone Metastasis
• Hormonal Therapy

Diagnostic Techniques Covered:
• Prostate Specific Antigen Test (PSA)
• Digital Rectal Exam (DRE)

End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Pharmacies
• Specialty Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub-segments, and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Featured Research Reports

  • Featured Research Reports

    Global Rheumatoid Arthritis Drugs Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Kidney Cancer Drugs Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Dilated Cardiomyopathy Therapeutics Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Pharmacovigilance Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Pulmonary Arterial Hypertension (PAH) Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...